Selling, General & Admin | 58.38 | 65.41 | 63.78 | 13.55 | 3.56 |
Research & Development | 212.16 | 228.06 | 481.34 | 55.63 | 38.23 |
Operating Expenses | 270.55 | 293.46 | 545.12 | 69.18 | 41.79 |
Operating Income | -270.55 | -293.46 | -545.12 | -69.18 | -41.79 |
Interest & Investment Income | 26.72 | 31.21 | 30.56 | 4.05 | - |
Currency Exchange Gain (Loss) | - | - | - | -0.1 | - |
Other Non Operating Income (Expenses) | 9.69 | 11.41 | -0.63 | 0.46 | -0.05 |
EBT Excluding Unusual Items | -234.14 | -250.85 | -515.19 | -64.77 | -41.84 |
Merger & Restructuring Charges | -21.39 | -21.39 | -10 | - | - |
Gain (Loss) on Sale of Investments | 18.41 | 18.41 | 10.5 | - | - |
Gain (Loss) on Sale of Assets | - | 7 | - | - | - |
Other Unusual Items | -31.4 | -1.4 | - | - | - |
Pretax Income | -268.52 | -248.23 | -381.64 | -64.77 | -41.84 |
Net Income | -268.52 | -248.23 | -381.64 | -64.77 | -41.84 |
Net Income to Common | -268.52 | -248.23 | -381.64 | -64.77 | -41.84 |
Shares Outstanding (Basic) | 100 | 99 | 70 | 2 | 1 |
Shares Outstanding (Diluted) | 100 | 99 | 70 | 2 | 1 |
Shares Change (YoY) | 11.59% | 41.35% | 4410.31% | 126.58% | - |
EPS (Basic) | -2.69 | -2.50 | -5.43 | -41.59 | -60.87 |
EPS (Diluted) | -2.69 | -2.50 | -5.43 | -41.59 | -60.87 |
Free Cash Flow | -286.77 | -305.17 | -172 | -61.52 | -4.98 |
Free Cash Flow Per Share | -2.87 | -3.07 | -2.45 | -39.50 | -7.24 |
EBITDA | -270.06 | -293.04 | -545.01 | - | - |
D&A For EBITDA | 0.48 | 0.42 | 0.12 | - | - |
EBIT | -270.55 | -293.46 | -545.12 | -69.18 | -41.79 |